Clinical Trials Logo

Contraception clinical trials

View clinical trials related to Contraception.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06330428 Recruiting - Contraception Clinical Trials

Investigation of the Effect of Sexuality-Based Family Planning Education Given to Women Via Podcast on Contraceptive Method Selection and Sexual Life Quality

Start date: February 9, 2024
Phase: N/A
Study type: Interventional

In this study, it was aimed to examine the effect of Sexuality-Based Family Planning Education given to women of childbearing age via Podcast on contraceptive method selection and sexual life quality. Accordingly, the hypotheses of the study are as follows: Hypotheses of the Project H1: Sexuality-based family planning education via podcast has an effect on women's conscious and appropriate contraceptive method selection. H2: Sexuality-based family planning education via podcast has a positive effect on women's sexual life quality. H3: Sexuality-based family planning education via podcast has a positive effect on the quality of sexual life of women by increasing their level of contraceptive knowledge. H4: Sexuality-based family planning education via podcast has a positive effect on women's attitudes towards family planning.

NCT ID: NCT06296797 Recruiting - Contraception Clinical Trials

Patient-centered Information on Permanent Contraception

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

The goal of this study is to understand whether providing information to women with a strong desire to avoid future pregnancy about how tubal sterilization compares to long-acting reversible contraceptives improves perceived access to available contraceptives. Participants will: - Complete a baseline survey - Receive access to web-based educational resources - Complete a brief follow up survey immediately after exploring these web-based resources - Complete a follow-up survey 3 months after enrolling The investigators will compare outcomes among participants provided with access to a new website (intervention) summarizing recent patient-centered outcomes research (PCOR) comparing interval laparoscopic tubal sterilization and long-acting reversible contraception (LARC) to control participants provided with access to the existing Planned Parenthood website on tubal sterilization.

NCT ID: NCT06273670 Recruiting - Contraception Clinical Trials

Postpartum Initiation of Long-acting Reversible Contraceptives: Knowledge Attitude and Practice Study (KAP)

KAP
Start date: June 15, 2023
Phase:
Study type: Observational

Comparing Knowledge, attitude and Practice of clients and service providers about the regular (6 weeks) versus earlier initiation of LARC, through a structured questionnaire prepared in English and translated to local language i.e. Arabic.

NCT ID: NCT06230770 Recruiting - Contraception Clinical Trials

Impact of Progestin-only Contraception on Bleeding Patterns in Individuals Initiating GATT

Start date: February 1, 2024
Phase:
Study type: Observational

Gender diverse individuals who use gender-affirming testosterone therapy (GATT) to reduce gender dysphoria may also use progestins for contraception and to manage or suppress uterine bleeding. Research is limited, however, regarding expected bleeding patterns for individuals who choose to initiate GATT concurrently with a progestin. Clinicians who prescribe GATT do not have sufficient data to adequately counsel patients on side effects of concurrent progestin use and therefore extrapolate from studies conducted in cisgender women. This study is a prospective cohort study evaluating bleeding patterns and satisfaction among patients initiating GATT with or without concurrent initiation of a progestin contraceptive. The results from this study will enable clinicians to more accurately counsel patients using GATT on how the use of a progestin might affect their bleeding and whether this differs by progestin method.

NCT ID: NCT06127199 Recruiting - Contraception Clinical Trials

Contraceptive Efficacy Study of Ovaprene

Start date: December 19, 2023
Phase: N/A
Study type: Interventional

This will be a multi-center, single arm, open-label study of Ovaprene, a non-hormonal intravaginal ring, to investigate the contraceptive effectiveness, safety and acceptability of Ovaprene.

NCT ID: NCT06067256 Recruiting - Contraception Clinical Trials

A Multicentre, Prospective, Open-label, Non-comparative Study

Start date: July 20, 2023
Phase: Phase 4
Study type: Interventional

As there are no recent studies conducted in Italy on the profile of this COC, the purpose of this study is to evaluate its efficacy and tolerability in a given subset of women residing in Italy that are in need of contraception. Evaluate the cycle control: breakthrough bleeding (bleeding and/or spotting between cyclically regular onset of menses) of monophasic oral contraceptive pill Effimia® (NGM250 + EE35) in a population of women residing in Italy.

NCT ID: NCT06028555 Recruiting - Contraception Clinical Trials

International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study

INAS-NEES
Start date: June 28, 2023
Phase:
Study type: Observational

Multinational, comparative, prospective, active surveillance study that follows two cohorts. The primary objective of the study is to characterize and compare the risks of E4/Drospirenone (DRSP) with levonorgestrel-containing combined oral contraceptives (EE/LNG) in a study population that is representative of the actual users of these preparations. The main clinical outcome of interest is venous thromboembolism (VTE), specifically deep venous thrombosis (DVT) and pulmonary embolism (PE). Secondary objectives include measuring the occurrence of unintended pregnancy, assessing the risk of arterial thromboembolism (ATE), describing the drug utilization pattern, describing the baseline risk profile for VTE and ATE, and investigating outcomes associated with foetal exposure to E4/DRSP.

NCT ID: NCT06019533 Recruiting - Contraception Clinical Trials

A Trial on Contraceptive Efficacy, Safety and Tolerability of LVDS (Levonorgestrel Vaginal Delivery System) During 13 Cycles

Start date: August 9, 2023
Phase: Phase 3
Study type: Interventional

Multicentre, single arm phase III trial to assess the pearl index of LVDS. The trial lasts 13 cycles.The assessments include (but are not limited to) recording demographic data, pregnancy tests, gynaecological examinations, laboratory tests and a quality of life questionnaire. Adolescents will undergo DXA scans to measure bone mineral density (at selected sites only). The women will be provided with an e-diary app for their smartphone, to record IP use and vaginal bleeding.

NCT ID: NCT06009783 Recruiting - Contraception Clinical Trials

Utility of ChatGPT in Pre-vasectomy Counselling in an Office-based Setting

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

The investigators wish to perform a pilot study at the Manitoba Men's Health Clinic to assess if pre-vasectomy counseling with ChatGPT can safely streamline the consultation process by reducing visit times, while increasing patient satisfaction with the consultation process.

NCT ID: NCT05994599 Recruiting - Contraception Clinical Trials

Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring

Start date: July 28, 2023
Phase: Phase 1
Study type: Interventional

Single Dose Crossover Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring (Delivering 0.015 mg/0.12 mg Per Day) Worn for 21 Days in Healthy Female Subjects